NAUTILUS BIOTECHNOLOGY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.67 USD | -3.96% |
|
+13.14% | -10.70% |
| 30/04 | Transcript : Nautilus Biotechnology, Inc., Q1 2024 Earnings Call, Apr 30, 2024 | |
| 30/04 | Nautilus Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Nautilus Biotechnology, Inc.
24b0a7a01f2b11b34128d671fe.WaGWyI5I1NGwgR7ccMSkqfIuCUj3ktLdSt247_gHtzA.ENKl-OUAtYLTw0nuIIHlypt4OQCWopeSP630q8s03Xkz1tv_2hmQmMOwfQ~5aa2260fdfc8f5848a0881c91a485817
Upcoming events on Nautilus Biotechnology, Inc.
Past events on Nautilus Biotechnology, Inc.
| 30/04/2024 06:00 pm | Q1 2024 Earnings Call |
| 30/04/2024 | Q1 2024 Earnings Release Pre-market |
| 07/03/2024 12:00 am | TD Cowen Health Care Conference |
| 28/02/2024 07:00 pm | Q4 2023 Earnings Call |
| 28/02/2024 06:30 pm | Q4 2023 Earnings Release |
| 31/10/2023 06:00 pm | Q3 2023 Earnings Call |
| 31/10/2023 05:35 pm | Q3 2023 Earnings Release |
| 21/09/2023 08:00 pm | Gilmartin Group Emerging Growth Company Showcase |
| 13/09/2023 08:20 pm | Morgan Stanley Global Healthcare Conference |
| 15/08/2023 | UBS Genomics 2.0 and MedTech Innovations Summit |
| 10/08/2023 07:30 pm | Canaccord Genuity Growth Conference - Panel |
| 02/08/2023 06:00 pm | Q2 2023 Earnings Call |
| 02/08/2023 05:00 pm | Q2 2023 Earnings Release |
| 14/06/2023 10:30 pm | Annual General Meeting |
| 13/06/2023 05:10 am | Goldman Sachs Global Healthcare Conference |
| 08/06/2023 10:30 pm | Jefferies Global Healthcare Conference |
| 02/05/2023 06:00 pm | Q1 2023 Earnings Call |
| 02/05/2023 04:00 pm | Q1 2023 Earnings Release |
| 06/04/2023 11:00 pm | B. Riley Securities Disruptive Biotech Enabling Technologies Conference - Fireside Chat |
| 07/03/2023 01:20 am | Cowen Health Care Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,61 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -41,5 -47,8 13.13% | -52,0 -66,0 21.13% | -62,2 -72,1 13.78% | -91,9 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -50,5 -51,1 1.2% | -63,6 -66,7 4.67% | -76,2 -77,6 1.87% | -95,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -50,3 -50,3 -0.03% | -57,9 -62,1 6.72% | -63,7 -72,3 11.93% | -96,0 |
|
Net income Million USD | Released Forecast Spread | -15,6 | -50,3 -50,3 -0.03% | -57,9 -62,1 6.72% | -63,7 -72,3 11.93% | -96,0 |
|
EPS USD | Released Forecast Spread | 0,00 | -0,60 -0,70 14.29% | -0,46 -0,50 8% | -0,51 -0,58 12.07% | -0,75 |
| Announcement Date | 26/03/21 | 24/02/22 | 23/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,17 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,31 | 1,09 | 2,00 |
|
EBITDA Million USD | Released Forecast Spread | -13,6 -18,2 25.1% | -12,6 -19,0 33.56% | -12,6 -20,1 37.11% | -13,1 -25,4 48.33% | -14,8 -15,3 3.17% | -15,5 -15,4 -0.5% | -15,5 -18,6 16.66% | -16,4 -18,8 12.91% | -18,0 -17,2 -4.52% | -18,7 | -20,7 | -23,1 | -21,8 | -21,2 |
|
EBIT Million USD | Released Forecast Spread | -16,0 -18,8 14.78% | -15,5 -20,3 23.78% | -15,8 -18,4 14.02% | -16,3 -19,2 15.23% | -18,1 -18,8 3.77% | -19,0 -20,0 4.76% | -19,1 -21,4 10.66% | -20,0 -20,7 3.53% | -21,6 -21,8 1.04% | -22,6 | -24,6 | -26,5 | -25,1 | -25,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,8 -20,0 21.19% | -14,7 -21,4 31.36% | -14,1 -17,9 21.22% | -13,4 -17,5 23.38% | -15,0 -19,6 23.45% | -15,8 -20,2 21.74% | -15,9 -21,5 26.15% | -17,0 -19,4 12.02% | -18,7 -20,5 8.63% | -22,5 | -24,9 | -27,0 | -27,9 | -27,2 |
|
Net income Million USD | Released Forecast Spread | -15,8 -20,0 21.19% | -14,7 -21,4 31.36% | -14,1 -17,9 21.22% | -13,4 -17,5 23.38% | -15,0 -19,6 23.45% | -15,8 -20,2 21.74% | -15,9 -21,5 26.15% | -17,0 -19,4 12.02% | -18,7 -20,5 8.63% | -22,5 | -24,9 | -27,0 | -27,9 | -27,2 |
|
EPS USD | Released Forecast Spread | -0,13 -0,16 18.75% | -0,12 -0,17 29.41% | -0,11 -0,15 24.14% | -0,11 -0,14 21.43% | -0,12 -0,16 22.58% | -0,13 -0,14 7.14% | -0,13 -0,12 -8.33% | -0,14 -0,15 6.67% | -0,15 -0,16 6.25% | -0,18 | -0,20 | -0,21 | -0,22 | -0,22 |
| Announcement Date | 03/05/22 | 02/08/22 | 01/11/22 | 23/02/23 | 02/05/23 | 02/08/23 | 31/10/23 | 28/02/24 | 30/04/24 | - | - | - | - | - |
More events
Past sector events for Nautilus Biotechnology, Inc.
| 02/05/2024 05:30 pm | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:00 pm | MODERNA, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | INTELLIA THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NAUT Stock
- Calendar Nautilus Biotechnology, Inc.
